- Report
- December 2023
- 62 Pages
Global
From €6718EUR$6,995USD£5,784GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €480EUR$500USD£413GBP
- Report
- January 2019
- 35 Pages
Global
From €960EUR$1,000USD£827GBP
Colcrys (colchicine) is a medication used to treat gout and other inflammatory conditions. It is a member of the Immune Disorders Drugs class, which includes medications that reduce inflammation and suppress the immune system. Colcrys works by blocking the production of certain proteins that cause inflammation. It is also used to prevent and treat attacks of gouty arthritis.
Colcrys is available in both generic and brand-name forms. It is typically taken orally, but can also be administered intravenously. Common side effects include nausea, vomiting, and diarrhea.
Colcrys is a widely used medication for treating gout and other inflammatory conditions. It is available in both generic and brand-name forms, and is typically taken orally.
Some companies in the Colcrys market include Takeda Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more